Page last updated: 2024-11-04

sarpogrelate and Pain

sarpogrelate has been researched along with Pain in 4 studies

sarpogrelate: structure given in first source

Pain: An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS.

Research Excerpts

ExcerptRelevanceReference
"The effects of intrathecally and systemically administered 5-hydroxytriptamine (5-HT)(2A) receptor antagonist, sarpogrelate on acute thermal or formalin induced pain were examined."7.73Effects of a 5-HT2A receptor antagonist, sarpogrelate on thermal or inflammatory pain. ( Nishiyama, T, 2005)
"Sarpogrelate hydrochloride, a selective 5-hydroxytryptamine 2A antagonist, is a widely used antiplatelet agent for the treatment of peripheral arterial disease (PAD)."5.22Efficacy and Safety of DP-R202 in Patients with Chronic Artery Occlusive Disease: Multicenter Randomized Double-blind Active-controlled Parallel Group Phase III Clinical Study. ( Ahn, YK; Chae, IH; Chang, KY; Cho, BR; Cho, DK; Choi, D; Choi, S; Chun, K; Han, KR; Hong, BK; Jin, HY; Kang, W; Kim, DI; Kim, DW; Kim, SH; Kim, YJ; Lee, HC; Lee, JW; Lee, NH; Lee, S; Lee, SR; Park, CG; Pyun, W; Shin, JH; Yu, CW, 2016)
"The effects of intrathecally and systemically administered 5-hydroxytriptamine (5-HT)(2A) receptor antagonist, sarpogrelate on acute thermal or formalin induced pain were examined."3.73Effects of a 5-HT2A receptor antagonist, sarpogrelate on thermal or inflammatory pain. ( Nishiyama, T, 2005)
"Sarpogrelate was administered intraperitoneally, locally (subcutaneously at the formalin test site) or intrathecally 10 min before formalin injection."1.31Antinociception in rat by sarpogrelate, a selective 5-HT(2A) receptor antagonist, is peripheral. ( Goto, F; Ishizaki, K; Obata, H; Saito, S, 2000)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kusakari, Y1
Yamasaki, K1
Aiba, S1
Lee, HC1
Lee, SR1
Han, KR1
Yu, CW1
Park, CG1
Ahn, YK1
Jin, HY1
Kim, DW1
Cho, DK1
Choi, S1
Kim, SH1
Chang, KY1
Lee, S1
Pyun, W1
Lee, NH1
Kang, W1
Hong, BK1
Cho, BR1
Chae, IH1
Shin, JH1
Chun, K1
Kim, DI1
Lee, JW1
Kim, YJ1
Choi, D1
Nishiyama, T1
Obata, H1
Saito, S1
Ishizaki, K1
Goto, F1

Trials

1 trial available for sarpogrelate and Pain

ArticleYear
Efficacy and Safety of DP-R202 in Patients with Chronic Artery Occlusive Disease: Multicenter Randomized Double-blind Active-controlled Parallel Group Phase III Clinical Study.
    Clinical therapeutics, 2016, Volume: 38, Issue:3

    Topics: Aged; Arteries; Double-Blind Method; Female; Humans; Male; Middle Aged; Pain; Pain Measurement; Peri

2016

Other Studies

3 other studies available for sarpogrelate and Pain

ArticleYear
Painful macules of hand cholesterol crystal embolization successfully treated with oral corticosteroid, statin, and sarpogrelate.
    The Journal of dermatology, 2014, Volume: 41, Issue:7

    Topics: Administration, Oral; Adrenal Cortex Hormones; Aged, 80 and over; Cholesterol; Crystallization; Drug

2014
Effects of a 5-HT2A receptor antagonist, sarpogrelate on thermal or inflammatory pain.
    European journal of pharmacology, 2005, May-23, Volume: 516, Issue:1

    Topics: Analgesics; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Hyperalgesia; Inflammation;

2005
Antinociception in rat by sarpogrelate, a selective 5-HT(2A) receptor antagonist, is peripheral.
    European journal of pharmacology, 2000, Sep-15, Volume: 404, Issue:1-2

    Topics: Analgesics; Animals; Male; Pain; Pain Measurement; Rats; Rats, Wistar; Receptors, Serotonin; Recepto

2000